Monday, 17 August 2026European Markets
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Platforms Move to Shore Up Trust as Leadership Shifts and AI-Adjacent Markets Wobble
Major AI and media platforms are converging on trust and accountability measures — Anthropic's Claude adding watermarks, Spotify labeling AI artists — just as OpenAI loses special-projects lead Brad Lightcap and Meta's Zuckerberg publishes a defensive manifesto on AI's societal role. In parallel, AI-adjacent financial dynamics are surfacing real stress: Wall Street firms are paying for privileged early access to Trump's Truth Social posts for trading edge, while Trump Media itself reports a $238M loss driven by falling crypto holdings, highlighting how information asymmetry and speculative digital assets are becoming entangled with AI-era platforms.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts report JPMorgan Chase & Co.'s revenue for the same fiscal period (FY 2025) with the same observation date (2025-12-31), but with different values: $182.447 billion vs. $185 billion. The ~1.4% difference ($2.553 billion) is too large to be explained by rounding alone and represents conflicting data for the identical time period.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,809
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,809 facts checked against source5,205 source documents archived
Work with this data → vianewsagency.com

CEGEDIM And ESSILORLUXOTTICA Have A High Dividend Yield And Return On Equity In The Healthcare Sector.

Loading stream...

(vianews) - cegedim (cgm.pa) is among this list of stock assets with the highest dividend rate and return on equity on the healthcare sector.

financial asset price forward dividend yield return on equity
cegedim (cgm.pa) €16.30 2.94% 5.4%
essilorluxottica (el.pa) €157.80 1.96% 6.15%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. cegedim (cgm.pa)

2.94% forward dividend yield and 5.4% return on equity

cegedim sa operates as a technology and services company in the digital data flow management for healthcare ecosystem and b2b, and business software publisher for healthcare and insurance professionals worldwide. it operates in two divisions, health insurance, hr and e-services; and healthcare professionals. the health insurance, hr and e-services division markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. this division also provides solutions for hosting, hr and payroll management outsourcing, and electronic data exchange services. the healthcare professionals division offers management software, databases, and solutions to doctors, allied health professionals, pharmacists, and healthcare facilities. the company was incorporated in 1969 and is headquartered in boulogne-billancourt, france. cegedim sa is a subsidiary of fcb sa.

earnings per share

as for profitability, cegedim has a trailing twelve months eps of €0.78.

pe ratio

cegedim has a trailing twelve months price to earnings ratio of 20.79. meaning, the purchaser of the share is investing €20.79 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.4%.

more news about cegedim.

2. essilorluxottica (el.pa)

1.96% forward dividend yield and 6.15% return on equity

essilorluxottica société anonyme engages in design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses in europe, middle east, africa, latin america, asia-pacific, and north america. it operates through professional solutions and direct to consumer segments. the company offers lens under the crizal, essilor, eyezen, kodak lens, oakley, optifog, ray-ban, transitions, vailux, and xperio brands. it also provides eyewear products under the ray-ban, oakley, persol, oliver peoples, alain mikli, costa del mar, arnette, vogue eyewear, bolon, molsion, and ossé brands. it engages in the wholesale of eyecare products, including distributors, opticians, independents, third party e-commerce platforms, etc.; and sells directly to consumers through the network of physical stores or its online channels. the company was formerly known as essilor international société anonyme and changed its name to essilorluxottica société anonyme in october 2018. essilorluxottica société anonyme was founded in 1849 and is headquartered in paris, france.

earnings per share

as for profitability, essilorluxottica has a trailing twelve months eps of €0.19.

pe ratio

essilorluxottica has a trailing twelve months price to earnings ratio of 830.53. meaning, the purchaser of the share is investing €830.53 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.15%.

yearly top and bottom value

essilorluxottica's stock is valued at €157.80 at 11:30 est, way below its 52-week high of €184.70 and way higher than its 52-week low of €132.70.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on may 22, 2023, the estimated forward annual dividend rate is 3.23 and the estimated forward annual dividend yield is 1.96%.

volume

today's last reported volume for essilorluxottica is 36415 which is 92.56% below its average volume of 489933.

more news about essilorluxottica.